EP1412320A4 - Verknüpfte cyclitole und deren polysulfatierte derivate - Google Patents

Verknüpfte cyclitole und deren polysulfatierte derivate

Info

Publication number
EP1412320A4
EP1412320A4 EP02742526A EP02742526A EP1412320A4 EP 1412320 A4 EP1412320 A4 EP 1412320A4 EP 02742526 A EP02742526 A EP 02742526A EP 02742526 A EP02742526 A EP 02742526A EP 1412320 A4 EP1412320 A4 EP 1412320A4
Authority
EP
European Patent Office
Prior art keywords
polysulpated
cyclitole
derivatives
polysulpated derivatives
connected cyclitole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02742526A
Other languages
English (en)
French (fr)
Other versions
EP1412320A1 (de
Inventor
Martin Gerhardt Banwell
Ligong Liu
Christopher Richard Parish
Craig Geoffrey Freeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australian National University
Original Assignee
Australian National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR6128A external-priority patent/AUPR612801A0/en
Priority claimed from AUPS1969A external-priority patent/AUPS196902A0/en
Application filed by Australian National University filed Critical Australian National University
Publication of EP1412320A1 publication Critical patent/EP1412320A1/de
Publication of EP1412320A4 publication Critical patent/EP1412320A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/10—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EP02742526A 2001-07-04 2002-07-04 Verknüpfte cyclitole und deren polysulfatierte derivate Withdrawn EP1412320A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPR6128A AUPR612801A0 (en) 2001-07-04 2001-07-04 Linked cyclitols and their polysulfated derivatives
AUPR612801 2001-07-04
AUPS1969A AUPS196902A0 (en) 2002-04-26 2002-04-26 Activities of linked cyclitols
AUPS196902 2002-04-26
PCT/AU2002/000884 WO2003004454A1 (en) 2001-07-04 2002-07-04 Linked cyclitols and their polysulfated derivatives

Publications (2)

Publication Number Publication Date
EP1412320A1 EP1412320A1 (de) 2004-04-28
EP1412320A4 true EP1412320A4 (de) 2006-01-25

Family

ID=25646743

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02742526A Withdrawn EP1412320A4 (de) 2001-07-04 2002-07-04 Verknüpfte cyclitole und deren polysulfatierte derivate

Country Status (3)

Country Link
EP (1) EP1412320A4 (de)
JP (1) JP2004532898A (de)
WO (1) WO2003004454A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200740733A (en) * 2005-06-22 2007-11-01 Progen Ind Ltd Small molecule glycosaminoglycan mimetics
US20110104173A1 (en) * 2006-10-20 2011-05-05 The Australian National University Inhibition of degradation of extracellular matrix
US11787783B2 (en) 2016-12-13 2023-10-17 Beta Therapeutics Pty Ltd Heparanase inhibitors and use thereof
WO2018107200A1 (en) 2016-12-13 2018-06-21 Beta Therapeutics Pty Ltd Heparanase inhibitors and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0865283A4 (de) * 1995-09-08 2005-07-20 Anadys Pharmaceuticals Inc 2-desoxystreptamin als molekulares gerüst zur herstellung funktionell und räumlich unterschiedlicher moleküle sowie diese enthaltende arzneimittel

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
B.J. PAUL ET AL, SYNTHESIS, no. 6, 2001, pages 952 - 956, XP002356262 *
J. CHEM. SOC., PERKIN TRAN. 1, T. HUDLICKY ET AL, no. 12, 1991, pages 2907 - 2918, XP008056072 *
See also references of WO03004454A1 *
X. XIE ET AL, J. BIOL. CHEM., vol. 275, no. 44, 2000, pages 34818 - 34825, XP001031395 *

Also Published As

Publication number Publication date
JP2004532898A (ja) 2004-10-28
WO2003004454A1 (en) 2003-01-16
EP1412320A1 (de) 2004-04-28

Similar Documents

Publication Publication Date Title
ATE407131T1 (de) Substituierte bipiperidine -zwischenverbindungen und deren derivate
DE60230591D1 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
DE60237580D1 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
DE60215179D1 (de) Dolastatin 10 derivate
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
DE60326611D1 (de) N und dergleichen
NO20041975L (no) Bicyklisk oksopyridin og oksopyrimidinderivater
EP1412378A4 (de) Aptamere und antiaptamere
ATE261933T1 (de) Admantan derivate
DE60105859D1 (de) Urazil Verbindungen und deren Verwendung
ATE294171T1 (de) Phenylsulfonyl-1,3-dihydro-2h-indol-2-on derivate,deren herstellung und deren therapeutische verwendung
DE60319951D1 (de) Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
ATE470675T1 (de) Immunoglobulinvarianten und deren verwendungen
DK1427709T3 (da) 3-substituerede 4-pyrimidonderivater
ATE416185T1 (de) Sapogenin derivate, deren synthese und verwendung
ATE348805T1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
ATE273962T1 (de) 5-phenyl-pyrimidine derivate
DE69903143D1 (de) Chromanon und thiochromanon derivate
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DE60105020D1 (de) 6-phenylpyrrolopyrimidindion derivate
DE60230245D1 (de) Wabenkonstruktion und deren zusammenbau
DE60216345D1 (de) Gummimischung und deren Verwendung
ATE312828T1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
DE60216815D1 (de) Perfluoradamantylacrylatverbindung und zwischenprodukt dafür
DE50206476D1 (de) Cyanoanthranylamid-derivate und deren verwendung als arzneimittel

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040130

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20051212

17Q First examination report despatched

Effective date: 20060601

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070619